| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
13 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-3 |
| Cash Flow (TTM) (Millions $) |
1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Forbion European Acquisition Corp is a special purpose acquisition company (SPAC) that was formed with the purpose of acquiring or merging with a European life sciences company. SPACs are shell companies that raise capital through an initial public offering (IPO) and then use those funds to acquire an existing operating company.
Forbion European Acquisition Corp was specifically established to focus on the European life sciences sector, which includes pharmaceuticals, biotechnology, and medical device companies. The SPAC aims to identify and target potential acquisition opportunities in this industry with promising growth potential.
Once Forbion European Acquisition Corp identifies a suitable target, the company will negotiate the terms of the acquisition or merger, and if successful, the acquired company will become a publicly traded entity through the SPAC. This approach allows the target company to access the public markets and potentially secure additional funding for its operations and growth plans.
Overall, Forbion European Acquisition Corp aims to provide investors with an opportunity to invest in a European life sciences company through its SPAC structure, thereby potentially gaining exposure to an industry known for innovation, research and development, and significant growth potential.
Company Address: 4001 Kennett Pike Wilmington 19807 DE
Company Phone Number: 273-0765 Stock Exchange / Ticker: NASDAQ FRBN
|
%